GGrantIndex
← Leaderboards

Mary G Sorci-Thomas

Wake Forest University

Google Scholar ↗PubMed ↗ORCID ↗
$15,439,227
Attributed
$20,677,339
Total exposure
12
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.8M · FY2005–25
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$20,677,339 · 12

By mechanism

R01$15,732,077 · 6
P01$2,533,054 · 2
T32$2,194,208 · 1
R56$195,000 · 1
R13$23,000 · 2

Top collaborators

Most similar at Wake Forest University

Same institution · by research overlap

Others in their field

Top investigators on “Atherosclerosis”

Research focus

AtherosclerosisHigh Density LipoproteinsCholesterolCellsProteinsPlasmaInflammatoryLipidsLiverBasePlayIn VitroApolipoprotein A-IPreventMediatingReverse Cholesterol TransportCholesterol EstersCholesterol HomeostasisEquilibriumMouse ModelLinkComplexApolipoproteinsPhenotype

Grant awards (51)

Pcpe2 in Adipose Tissue Expansion and Lipoprotein Metabolism$655,834
R01 · FY2025 · DK · contact PI
Training in Signature Transdisciplinary Cardiovascular Sciences$571,962
T32 · FY2025 · HL · contact PI
Pcpe2 in Adipose Tissue Expansion and Lipoprotein Metabolism$683,834
R01 · FY2024 · DK · contact PI
Training in Signature Transdisciplinary Cardiovascular Sciences$553,947
T32 · FY2024 · HL
Training in Signature Transdisciplinary Cardiovascular Sciences$542,217
T32 · FY2023 · HL
Role of Pcpe2 in Adipose Tissue Remodeling and Lipoprotein Metabolism$195,000
R56 · FY2023 · DK · contact PI
Training in Signature Transdisciplinary Cardiovascular Sciences$526,082
T32 · FY2022 · HL
SR-BI and PCPE2: Novel partners in bi-directional cholesterol transport$690,570
R01 · FY2021 · HL · contact PI
American Heart Association Vascular Discovery: From Genes to Medicine Scientific Sessions$10,000
R13 · FY2021 · HL · contact PI
SR-BI and PCPE2: Novel partners in bi-directional cholesterol transport$690,570
R01 · FY2020 · HL · contact PI
SR-BI and PCPE2: Novel partners in bi-directional cholesterol transport$690,570
R01 · FY2019 · HL · contact PI
SR-BI and PCPE2: Novel partners in bi-directional cholesterol transport$690,570
R01 · FY2018 · HL · contact PI
Biogenesis of HDL Through Cholesterol Efflux and ApoA-I Structural Reorganization$537,006
R01 · FY2018 · HL · contact PI
Biogenesis of HDL Through Cholesterol Efflux and ApoA-I Structural Reorganization$537,006
R01 · FY2017 · HL · contact PI
T Regulatory Lymphocytes, HDL Function, and Atherosclerosis$692,467
R01 · FY2016 · HL
Biogenesis of HDL Through Cholesterol Efflux and ApoA-I Structural Reorganization$536,241
R01 · FY2016 · HL · contact PI
T Regulatory Lymphocytes, HDL Function, and Atherosclerosis$697,733
R01 · FY2015 · HL
Biophysics of HDL Dysfunction$591,775
R01 · FY2015 · HL
Biogenesis of HDL Through Cholesterol Efflux and ApoA-I Structural Reorganization$547,197
R01 · FY2015 · HL · contact PI
T Regulatory Lymphocytes, HDL Function, and Atherosclerosis$685,489
R01 · FY2014 · HL
Biophysics of HDL Dysfunction$643,959
R01 · FY2014 · HL
T Regulatory Lymphocytes, HDL Function, and Atherosclerosis$29,441
R01 · FY2014 · HL
T Regulatory Lymphocytes, HDL Function, and Atherosclerosis$707,427
R01 · FY2013 · HL
Biophysics of HDL Dysfunction$628,118
R01 · FY2013 · HL
Inflammation, Atherosclerosis and ApoA-I$348,718
R01 · FY2013 · HL · contact PI
Biophysics of HDL Dysfunction$18,866
R01 · FY2013 · HL
Biophysics of HDL Dysfunction$633,807
R01 · FY2012 · HL
Inflammation, Atherosclerosis and ApoA-I$366,300
R01 · FY2012 · HL · contact PI
Structural Relationship Between APO A-1 Comformation and the Extent of Particle L$257,421
P01 · FY2012 · HL · contact PI
Inflammation, Atherosclerosis and ApoA-I$370,000
R01 · FY2011 · HL · contact PI
Structural Relationship Between APO A-1 Comformation and the Extent of Particle L$257,421
P01 · FY2011 · HL · contact PI
Inflammation, Atherosclerosis and ApoA-I$370,000
R01 · FY2010 · HL · contact PI
Structural Relationship Between APO A-1 Comformation and the Extent of Particle L$257,421
P01 · FY2010 · HL · contact PI
Structural Relationship Between APO A-1 Comformation and the Extent of Particle L$257,421
P01 · FY2009 · HL · contact PI
Inflammation and Inhibition of Cholesterol Transport$340,161
R01 · FY2008 · HL · contact PI
Structural Relationship Between APO A-1 Comformation and the Extent of Particle L$257,421
P01 · FY2008 · HL · contact PI
Inflammation and Inhibition of Cholesterol Transport$340,161
R01 · FY2007 · HL · contact PI
Structure/Function Relationships of APO A-I$278,508
P01 · FY2007 · HL · contact PI
Inflammation and Inhibition of Cholesterol Transport$350,319
R01 · FY2006 · HL · contact PI
Structure/Function Relationships of APO A-I$263,687
P01 · FY2006 · HL · contact PI
2006 Lipoprotein Metabolism Gordon Conference$13,000
R13 · FY2006 · HL · contact PI
Inflammation and Inhibition of Cholesterol Transport$358,750
R01 · FY2005 · HL
Structure/Function Relationships of APO A-I$256,010
P01 · FY2005 · HL
Structure/Function Relationships of APO A-I$248,552
P01 · FY2004 · HL
APO A-1 STRUCTURAL MUTATION AND ATHEROSCLEROSIS$324,000
R01 · FY2003 · HL
APO A-1 STRUCTURAL MUTATION AND ATHEROSCLEROSIS$324,000
R01 · FY2002 · HL
STRUCTURE/FUNCTION RELATIONSHIPS OF APOLIPOPROTEIN A (APOA-1)$0
P01 · FY2002 · HL
APO A-1 STRUCTURAL MUTATION AND ATHEROSCLEROSIS$325,031
R01 · FY2001 · HL
STRUCTURE/FUNCTION RELATIONSHIPS OF APOLIPOPROTEIN A (APOA-1)$0
P01 · FY2001 · HL
APO A-1 STRUCTURAL MUTATION AND ATHEROSCLEROSIS$326,157
R01 · FY2000 · HL
STRUCTURE/FUNCTION RELATIONSHIPS OF APOLIPOPROTEIN A (APOA-1)$199,192
P01 · FY2000 · HL